Peptide-Based mRNA Vaccine Demonstrates 70% Tumor Shrinkage in Neuroblastoma Trials A peptide-based mRNA vaccine showed significant promise in reducing neuroblastoma tumors by 70% in early clinical trials, according to a …
Tag: